Vai al contenuto principale
Coronavirus: aggiornamenti per la comunità universitaria / Coronavirus: updates for UniTo Community
Oggetto:

ADE - OVERVIEW AND CHALLENGES IN THE MANAGEMENT OF AUTO-INFLAMMATORY DISEASES

Oggetto:

ADE - OVERVIEW AND CHALLENGES IN THE MANAGEMENT OF AUTO-INFLAMMATORY DISEASES

Oggetto:

Academic year 2022/2023

Course ID
SCB0459
Teachers
Prof. Savino Sciascia (Lecturer)
Prof. Simone Baldovino (Lecturer)
Year
4th year
Teaching period
Second semester
Type
Elective
Credits/Recognition
1
Course disciplinary sector (SSD)
MED/05 - clinical pathology
MED/14 - nephrology
Delivery
Formal authority
Language
English
Attendance
Mandatory
Type of examination
Quiz
Oggetto:

Sommario del corso

Oggetto:

Course objectives

  • to review the main screening, diagnostic and therapeutic aspects of auto-inflammatory diseases
  • to identify the main clinical and laboratory conditions related to the auto-inflammatory diseases
  • to identify the main management protocols for auto-inflammatory diseases
Oggetto:

Results of learning outcomes

Students are expected to obtain an in-depth knowledge about
a) the pathology and pathophysiology of auto-inflammatory diseases
b) laboratory values from routine blood examination and be able to differentiate between pathologies.
c) differential diagnosis based on clinical examination and laboratory values.
d) basic understanding of the treatment protocols in place for auto-inflammatory diseases

Oggetto:

Program

  • Definition of auto-inflammatory diseases
  • Diagnosis and treatment of auto-inflammatory diseases
Oggetto:

Course delivery

In person as flipped classroom

Oggetto:

Learning assessment methods

Multiple Choice Answers Quiz

Suggested readings and bibliography

Oggetto:

Recent Research Article as provided at the time of the enrollment



Enroll
  • Closed
    Enrollment opening date
    01/11/2022 at 00:00
    Enrollment closing date
    01/04/2023 at 00:00
    Maximum number of students
    50 (Once this number of students is reached, enrollment will no longer be permitted!)
    Oggetto:
    Last update: 17/08/2022 09:43
    Non cliccare qui!